The digital diabetes developer Glooko has collected $100 million and a new CEO to help boost the trajectory of its data ...

Ono Pharmaceutical has bought a seat in a quiet corner of the congested antibody-drug conjugate (ADC) space, agreeing | Ono ...

Booster Therapeutics has launched with $15 million in seed financing and a mission to take on the current crop of targeted ...

Immatics has vaulted into phase 3 on the strength of early-stage data. The biotech is gearing up to start a pivotal trial of ...

Cytovale has raised $100 million in venture capital funding to support its rapid test for determining a patient’s sepsis risk ...

Gritstone bio may have left no stone unturned when it came to searching for a financial rescue, but the vaccine biotech has ...

Some six years after picking up Seattle’s Universal Cells for $102 million, Astellas Pharma is opening a second location for ...